gladstone.org
Open in
urlscan Pro
2620:12a:8001::3
Public Scan
Submitted URL: http://www.humancell.org/
Effective URL: https://gladstone.org/
Submission: On June 28 via api from US — Scanned from DE
Effective URL: https://gladstone.org/
Submission: On June 28 via api from US — Scanned from DE
Form analysis 2 forms found in the DOM
GET /google-search
<form action="/google-search" method="GET">
<input id="search-input" class="search-input" placeholder="Search Keyword(s)" type="text" name="q" style="display:none">
<input type="submit" value="Submit" style="display:none">
</form>Name: mc-embedded-subscribe-form — POST https://gladstoneinstitutes.us10.list-manage.com/subscribe/post?u=1a62a392ffda799ebdf0313d3&id=f25fc65fc1
<form action="https://gladstoneinstitutes.us10.list-manage.com/subscribe/post?u=1a62a392ffda799ebdf0313d3&id=f25fc65fc1" method="post" id="mc-embedded-subscribe-form" name="mc-embedded-subscribe-form" class="validate" target="_blank"
novalidate="">
<div id="mc_embed_signup_scroll">
<div class="mc-field-group">
<input type="email" value="" name="EMAIL" class="required email" id="mce-EMAIL" placeholder="Email Address"><label for="mce-EMAIL" class="form-label-hide">Email Address</label>
</div>
<div id="mce-responses" class="clear">
<div class="response" id="mce-error-response" style="display:none"></div>
<div class="response" id="mce-success-response" style="display:none"></div>
</div> <!-- real people should not fill this in and expect good things - do not remove this or risk form bot signups-->
<div style="position: absolute; left: -5000px;" aria-hidden="true"><input type="text" id="whatsamattau" name="b_1a62a392ffda799ebdf0313d3_f25fc65fc1" tabindex="-1" value=""><label for="whatsamattau" class="form-label-hide">Comments</label></div>
<div class="clear"><input type="submit" value="Subscribe" name="subscribe" id="mc-embedded-subscribe"></div>
</div>
</form>Text Content
Press Alt+1 for screen-reader mode, Alt+0 to cancelAccessibility Screen-Reader Guide, Feedback, and Issue Reporting Menu * About Open submenu * Science Open submenu * Training Open submenu * News Open submenu * Events * Give Close submenuAbout * People Open submenu * Outreach * Core Values * Diversity, Equity, and Inclusion * Finances * Gladstone Foundation * History * Ogawa-Yamanaka Stem Cell Prize * Contact Close submenuPeople * Investigators * Leadership * Trustees * Gladstone Foundation Close submenuScience * Institutes Open submenu * Centers * Core Facilities Open submenu * Investigators * Industry Partners Open submenu * Programs Open submenu Close submenuInstitutes * Cardiovascular Disease Institute * Data Science and Biotechnology Institute * Genomic Immunology Institute * Neurological Disease Institute * Virology Institute Close submenuCore Facilities * Assay Development and Drug Discovery Core * Behavioral core * Bioinformatics Core * Flow Cytometry Core * Genomics Core * Histology and Light Microscopy Core * Mass Spectrometry Facility * Stem Cell Core * Transgenic Gene Targeting Core Close submenuIndustry Partners * Cure Network Ventures * Licensing Close submenuPrograms * BioFulcrum Open submenu * Hope Collaboratory Close submenuBioFulcrum * Heart Failure Research Program * Viral and Infectious Disease Research Program Close submenuTraining * Academic Affairs Open submenu * Postdocs * Graduate Students * Embark: Presidential Postdoctoral Program Open submenu * NOMIS–Gladstone Fellowship Program * PUMAS Summer Internship Program Open submenu Close submenuAcademic Affairs * Living and Working in San Francisco Close submenuEmbark: Presidential Postdoctoral Program * Apply Close submenuPUMAS Summer Internship Program * PUMAS Application Instructions Close submenuNews * For Media Skip to main content Menu * About * People * Outreach * Core Values * Diversity, Equity, and Inclusion * Finances * Gladstone Foundation * History * Ogawa-Yamanaka Stem Cell Prize * Contact * Science * Institutes * Centers * Core Facilities * Investigators * Industry Partners * Programs * Training * Academic Affairs * Postdocs * Graduate Students * Embark: Presidential Postdoctoral Program * NOMIS–Gladstone Fellowship Program * PUMAS Summer Internship Program * News * For Media * Events * Give SCIENCE OVERCOMING DISEASE Gladstone is an independent biomedical research organization tackling the biggest problems in human health. We disrupt how science is done to make discoveries that change lives. The Gladstone Difference Deepak Srivastava Honored as Most Admired CEO The San Francisco Business Times has recognized Srivastava as one of the Bay Area's most revered executives. May 10, 2024 Using the Power of AI to Outsmart Cancer Funds will ignite a fresh wave of discoveries using computational biology and AI. March 12, 2024 Ogawa-Yamanaka Stem Cell Prize: Nominations Open The award celebrates scientists who advance regenerative medicine through cellular reprogramming. March 4, 2021 Deepak Srivastava Honored as Most Admired CEO The San Francisco Business Times has recognized Srivastava as one of the Bay Area's most revered executives. May 10, 2024 Using the Power of AI to Outsmart Cancer Funds will ignite a fresh wave of discoveries using computational biology and AI. March 12, 2024 Ogawa-Yamanaka Stem Cell Prize: Nominations Open The award celebrates scientists who advance regenerative medicine through cellular reprogramming. March 4, 2021 Deepak Srivastava Honored as Most Admired CEO The San Francisco Business Times has recognized Srivastava as one of the Bay Area's most revered executives. May 10, 2024 Using the Power of AI to Outsmart Cancer Funds will ignite a fresh wave of discoveries using computational biology and AI. March 12, 2024 Ogawa-Yamanaka Stem Cell Prize: Nominations Open The award celebrates scientists who advance regenerative medicine through cellular reprogramming. March 4, 2021 OUR Science Gladstone pushes the boundaries of scientific possibility through our five interconnected institutes. With a deep understanding of how the human body works and what goes wrong in disease, we focus on conditions with profound medical, economic, and social impact. OUR INSTITUTES Cardiovascular Disease Congenital Heart Disease Heart Failure Genetic Diseases Regenerative Medicine Learn about the Institute Data Science and Biotechnology Artificial Intelligence Computational Biology CRISPR Genome Editing Genetic Diseases Proteomics Synthetic Biology Learn about the Institute Genomic Immunology Cancer Autoimmune Diseases Infectious Diseases Primary Immunodeficiencies Learn about the Institute Neurological Disease Alzheimer’s Disease Other Dementias ALS Autism Epilepsy Huntington’s Disease Long COVID Multiple Sclerosis Parkinson’s Disease Rare Brain Diseases Spinal Cord Injury Traumatic Brain Injury Learn about the Institute Virology HIV/AIDS Antimicrobial-Resistant Infections COVID-19 and Long COVID Women’s Health Influenza Microbiome and Gut Health Phage Therapy Respiratory Viruses Hepatitis C Vaccine Development Zika Malaria Learn about the Institute LATEST NEWS Read All Computational Biology Pioneer Katie Pollard Elected as AAAS Fellow The American Association for the Advancement of Science (AAAS), one of the world’s largest general scientific societies, has elected Gladstone Senior Investigator Katie Pollard, PhD, into its new… April 18, 2024 Developing the UC San Francisco Gender Affirming Health Program: from DIY to the Big Leagues In this video recording from the 2024 Transgender Day of Visibility seminar, learn more about the development, launch, and growth of the UCSF Gender Affirming Health Program April 12, 2024 Gladstone Grad Student Shines on International Neuroscience Stage In early 2024, Deanna Necula co-chaired a prestigious Gordon Research Seminar in Ventura, California April 2, 2024 LinkedIn for Job Searching In this webinar, a former LinkedIn staffer shares behind-the-scenes insights to help you optimize the rate of return on the jobs you apply for. March 22, 2024 Meet Gladstone: Rama Dajani Rama Dajani, a research associate in Alex Marson's lab, discusses her early exposure to biotechnology, her research on HIV, and advice she has for women aspiring to pursue science. March 19, 2024 $5 Million Grant Bets on Computational Biology, AI to Change the Future of Cancer The Biswas Family Foundation and Milken Institute announce funding to establish a center for computational cancer biology at Gladstone Institutes, led by Senior Investigator Katie Pollard. March 12, 2024 Gladstone to Expand Stem Cell Research Capabilities with Multi-Million Dollar Regenerative Medicine Grant Funds from the California Institute for Regenerative Medicine will allow Gladstone to bolster its disease-modeling technologies, add robust CRISPR screening capabilities, and educate young… March 11, 2024 Barbara Engelhardt Elected Fellow of the International Society for Computational Biology The ISCB Fellows program is a prestigious recognition within the field of computational biology honoring those who have made outstanding contributions to the discipline. These distinguished… March 11, 2024 Justin Eyquem Named a 2024 Pew-Stewart Scholar for Cancer Research Eyquem, an affiliate investigator at Gladstone Institutes, is working to enhance the efficiency of CAR-T therapy, a cancer treatment that modifies T cells to target cancer cells. June 18, 2024 Out in Science: Creating Spaces for Success Watch a recording from the 2024 Out in Science event, featuring Carolyn Bertozzi, Chanda Prescod-Weinstein, and Joanne Engel June 18, 2024 Scientists Push Single-Molecule DNA Sequencing to the Next Level Two new tools created at Gladstone Institutes allow scientists to study DNA at single-molecule resolution using fewer cells than previously required, with clear applications for cancer and many other… June 4, 2024 CRISPR-Based Mapping Uncovers ‘Switches’ for Immune Genes Central to Health A new study in Nature Genetics expands our understanding of immune regulation and autoimmunity—with findings that could also be used in the development of cancer immunotherapies. May 29, 2024 Scientists Leverage Machine Learning to Decode Gene Regulation in the Developing Human Brain A team of researchers from Gladstone Institutes and UC San Francisco combined high-throughput experiments and machine learning to analyze more than 100,000 sequences in human brain cells. May 24, 2024 Gladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times The San Francisco Business Times has named Srivastava as one of the Most Admired CEOs among Bay Area businesses and nonprofits. The cardiologist and stem cell pioneer has served in the top leadership… May 10, 2024 A New Therapeutic Target for Traumatic Brain Injury Research from Gladstone Institutes reveals that a blood coagulation protein is responsible for initiating toxic inflammation and neuron loss after a major head injury. The findings can inform new… April 19, 2024 Computational Biology Pioneer Katie Pollard Elected as AAAS Fellow The American Association for the Advancement of Science (AAAS), one of the world’s largest general scientific societies, has elected Gladstone Senior Investigator Katie Pollard, PhD, into its new… April 18, 2024 Developing the UC San Francisco Gender Affirming Health Program: from DIY to the Big Leagues In this video recording from the 2024 Transgender Day of Visibility seminar, learn more about the development, launch, and growth of the UCSF Gender Affirming Health Program April 12, 2024 Gladstone Grad Student Shines on International Neuroscience Stage In early 2024, Deanna Necula co-chaired a prestigious Gordon Research Seminar in Ventura, California April 2, 2024 LinkedIn for Job Searching In this webinar, a former LinkedIn staffer shares behind-the-scenes insights to help you optimize the rate of return on the jobs you apply for. March 22, 2024 Meet Gladstone: Rama Dajani Rama Dajani, a research associate in Alex Marson's lab, discusses her early exposure to biotechnology, her research on HIV, and advice she has for women aspiring to pursue science. March 19, 2024 $5 Million Grant Bets on Computational Biology, AI to Change the Future of Cancer The Biswas Family Foundation and Milken Institute announce funding to establish a center for computational cancer biology at Gladstone Institutes, led by Senior Investigator Katie Pollard. March 12, 2024 Gladstone to Expand Stem Cell Research Capabilities with Multi-Million Dollar Regenerative Medicine Grant Funds from the California Institute for Regenerative Medicine will allow Gladstone to bolster its disease-modeling technologies, add robust CRISPR screening capabilities, and educate young… March 11, 2024 Barbara Engelhardt Elected Fellow of the International Society for Computational Biology The ISCB Fellows program is a prestigious recognition within the field of computational biology honoring those who have made outstanding contributions to the discipline. These distinguished… March 11, 2024 Justin Eyquem Named a 2024 Pew-Stewart Scholar for Cancer Research Eyquem, an affiliate investigator at Gladstone Institutes, is working to enhance the efficiency of CAR-T therapy, a cancer treatment that modifies T cells to target cancer cells. June 18, 2024 Out in Science: Creating Spaces for Success Watch a recording from the 2024 Out in Science event, featuring Carolyn Bertozzi, Chanda Prescod-Weinstein, and Joanne Engel June 18, 2024 Scientists Push Single-Molecule DNA Sequencing to the Next Level Two new tools created at Gladstone Institutes allow scientists to study DNA at single-molecule resolution using fewer cells than previously required, with clear applications for cancer and many other… June 4, 2024 CRISPR-Based Mapping Uncovers ‘Switches’ for Immune Genes Central to Health A new study in Nature Genetics expands our understanding of immune regulation and autoimmunity—with findings that could also be used in the development of cancer immunotherapies. May 29, 2024 Scientists Leverage Machine Learning to Decode Gene Regulation in the Developing Human Brain A team of researchers from Gladstone Institutes and UC San Francisco combined high-throughput experiments and machine learning to analyze more than 100,000 sequences in human brain cells. May 24, 2024 Gladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times The San Francisco Business Times has named Srivastava as one of the Most Admired CEOs among Bay Area businesses and nonprofits. The cardiologist and stem cell pioneer has served in the top leadership… May 10, 2024 A New Therapeutic Target for Traumatic Brain Injury Research from Gladstone Institutes reveals that a blood coagulation protein is responsible for initiating toxic inflammation and neuron loss after a major head injury. The findings can inform new… April 19, 2024 Computational Biology Pioneer Katie Pollard Elected as AAAS Fellow The American Association for the Advancement of Science (AAAS), one of the world’s largest general scientific societies, has elected Gladstone Senior Investigator Katie Pollard, PhD, into its new… April 18, 2024 Our scientists pursue research with extraordinary levels of creativity and courage. We recognize the momentous era in which we live and ask questions relentlessly, knowing the next key discovery may occur in an instant. OUR People Find an Expert Ken Nakamura, MD, PhD Associate Investigator, Gladstone Institutes Melanie Ott, MD, PhD Director, Gladstone Institute of Virology Jorge Palop, PhD Associate Investigator, Gladstone Institutes Jeanne Paz, PhD Associate Investigator, Gladstone Institutes Karin Pelka, PhD Assistant Investigator, Gladstone Institutes Alex Pico, PhD Research Investigator, Gladstone Institutes Katie Pollard, PhD Director, Gladstone Institute of Data Science and Biotechnology Vijay Ramani, PhD Assistant Investigator, Gladstone Institutes Nadia Roan, PhD Senior Investigator, Gladstone Institutes Seth Shipman, PhD Associate Investigator, Gladstone Institutes Deepak Srivastava, MD President, Gladstone Institutes Taha Taha, PharmD, PhD Research Investigator, Gladstone Institutes Catherine Tcheandjieu Gueliatcha, DVM, PhD Assistant Investigator, Gladstone Institutes Christina Theodoris, MD, PhD Assistant Investigator, Gladstone Institutes Kiichiro Tomoda, PhD Research Investigator, Gladstone Institutes Leor Weinberger, PhD Senior Investigator, Gladstone Institutes Shinya Yamanaka, MD, PhD Senior Investigator, Gladstone Institutes Andrew Yang, PhD Visiting Investigator, Gladstone Institutes Katerina Akassoglou, PhD Senior Investigator, Gladstone Institutes Michael Alexanian, PhD Assistant Investigator, Gladstone Institutes Benoit Bruneau, PhD Director, Gladstone Institute of Cardiovascular Disease Sonali Chaturvedi, PhD Research Investigator, Gladstone Institutes Bruce Conklin, MD Senior Investigator, Gladstone Institutes Ryan Corces, PhD Assistant Investigator, Gladstone Institutes Sheng Ding, PhD Senior Investigator, Gladstone Institutes Jennifer Doudna, PhD Senior Investigator, Gladstone Institutes Barbara Engelhardt, PhD Senior Investigator, Gladstone Institutes Steve Finkbeiner, MD, PhD Director, Center for Systems and Therapeutics Swetansu Hota, PhD Research Investigator, Gladstone Institutes Yadong Huang, MD, PhD Senior Investigator, Gladstone Institutes Isha Jain, PhD Assistant Investigator, Gladstone Institutes Nevan Krogan, PhD Senior Investigator, Gladstone Institutes Robert Mahley, MD, PhD President Emeritus and Senior Investigator, Gladstone Institutes Alex Marson, MD, PhD Director, Gladstone-UCSF Institute of Genomic Immunology Lennart Mucke, MD Director, Gladstone Institute of Neurological Disease Ken Nakamura, MD, PhD Associate Investigator, Gladstone Institutes Melanie Ott, MD, PhD Director, Gladstone Institute of Virology Jorge Palop, PhD Associate Investigator, Gladstone Institutes Jeanne Paz, PhD Associate Investigator, Gladstone Institutes Karin Pelka, PhD Assistant Investigator, Gladstone Institutes Alex Pico, PhD Research Investigator, Gladstone Institutes Katie Pollard, PhD Director, Gladstone Institute of Data Science and Biotechnology Vijay Ramani, PhD Assistant Investigator, Gladstone Institutes Nadia Roan, PhD Senior Investigator, Gladstone Institutes Seth Shipman, PhD Associate Investigator, Gladstone Institutes Deepak Srivastava, MD President, Gladstone Institutes Taha Taha, PharmD, PhD Research Investigator, Gladstone Institutes Catherine Tcheandjieu Gueliatcha, DVM, PhD Assistant Investigator, Gladstone Institutes Christina Theodoris, MD, PhD Assistant Investigator, Gladstone Institutes Kiichiro Tomoda, PhD Research Investigator, Gladstone Institutes Leor Weinberger, PhD Senior Investigator, Gladstone Institutes Shinya Yamanaka, MD, PhD Senior Investigator, Gladstone Institutes Andrew Yang, PhD Visiting Investigator, Gladstone Institutes Katerina Akassoglou, PhD Senior Investigator, Gladstone Institutes Michael Alexanian, PhD Assistant Investigator, Gladstone Institutes Benoit Bruneau, PhD Director, Gladstone Institute of Cardiovascular Disease Sonali Chaturvedi, PhD Research Investigator, Gladstone Institutes Bruce Conklin, MD Senior Investigator, Gladstone Institutes Ryan Corces, PhD Assistant Investigator, Gladstone Institutes Sheng Ding, PhD Senior Investigator, Gladstone Institutes Jennifer Doudna, PhD Senior Investigator, Gladstone Institutes Barbara Engelhardt, PhD Senior Investigator, Gladstone Institutes Steve Finkbeiner, MD, PhD Director, Center for Systems and Therapeutics Swetansu Hota, PhD Research Investigator, Gladstone Institutes Yadong Huang, MD, PhD Senior Investigator, Gladstone Institutes Isha Jain, PhD Assistant Investigator, Gladstone Institutes Nevan Krogan, PhD Senior Investigator, Gladstone Institutes Robert Mahley, MD, PhD President Emeritus and Senior Investigator, Gladstone Institutes Alex Marson, MD, PhD Director, Gladstone-UCSF Institute of Genomic Immunology Lennart Mucke, MD Director, Gladstone Institute of Neurological Disease Ken Nakamura, MD, PhD Associate Investigator, Gladstone Institutes BECOME A GLADSTONE POSTDOC OR GRADUATE STUDENT Gladstone is dedicated to training tomorrow’s leaders and disruptive scientists. We equip our trainees with a broad set of skills, so they can effect change to improve the world. Explore Training Program OUR COMMITMENT TO DIVERSITY, EQUITY, AND INCLUSION We believe that when we bring together people with diverse approaches and ideas to tackle scientific challenges in creative ways, we create tremendous opportunities to discover new treatments—and cures—for disease. We pride ourselves on learning from each member of our community to make sure our environment is welcoming to everyone. View Our Diversity Report Card OUR Environment About Us Located in the epicenter of biomedical innovation, Gladstone embraces a culture of collaboration across more than 30 laboratories, all under one roof. Our scientists are passionately interdisciplinary. There are no silos here—only progress. 600+ Scientists 45 Years of disease-driven research 189 Graduate students and postdocs 20 Core facilities and centers WANT TO JOIN THE TEAM? Forbes magazine named Gladstone one of America’s best small employers in 2023. That’s because we value the contribution of each individual toward scientific discovery. We work as one team with one goal: overcome disease. Explore Careers WE WORK WITH INDUSTRY PARTNERS, SUCH AS: Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients. Partner With Us Gladstone Institutes is an independent state-of-the-art biomedical research institution that empowers its world-class scientists to find new pathways to cures. STAY UP TO DATE WITH US Subscribe to our newsletter to receive monthly updates on the innovative discoveries, distinguishing awards, and noteworthy events taking place at Gladstone Institutes. Email Address Comments -------------------------------------------------------------------------------- 1650 Owens Street, San Francisco, CA 94158 Crisis Response and Building Safety 415.734.2000 © 2024 Gladstone Institutes All Rights Reserved Terms and Conditions Conflict of Interest Registered 501(c)(3). EIN: 23-7203666 Careers For Media Contact CONGRATS TO JENNIFER DOUDNA, WINNER OF THE 2020 NOBEL PRIZE IN CHEMISTRY! Read More Close menu